once-weekly semaglutide in persons with obesity and knee osteoarthritis Weight loss drug may offer relief for arthritis pain GLP-1s and Knee Osteoarthritis -
Description
Ortiz said he would recommend GLP-1 medications for people who meet criteria for overweight or obesity, citing the health risks associated with obesity
A phase 3 study in subjects 4 years of age and PWS do not show significant changes in body weight at 13 weeks, although lean body mass/fat mass ratio increase significantly in the treatment group (147)
Almaa J, Molina J, Menegaz D
Gains of 10 pounds or more can begin to alter the contour
Dor Abdominal
Gallbladder events rise modestly, especially with rapid loss
